Furthermore, concerns have been raised about the effectiveness of granulocyte colony-stimulating factor (G-CSF) in mobilizing stem/progenitor cells in clinical trials for coronary artery disease patients and its safety concerning its association with arterial restenosis and plaque instability [15,16]. The gene discussed is CSF3; the disease is coronary artery disorder.